Drug firm AstraZeneca Thursday said it has opened a new development operations centre in Bengaluru to support expansion of its clinical research footprint in India.
This expansion will focus on managing studies in India to not only support the global clinical drug development, but also the local business with clinical data and evidence, it added.
"Because of the excellent skills of Indian clinical research experts and the improvement of regulations and approval timelines, we are pleased to expand our operations and continue to lead clinical research in India," AstraZeneca Development Operations (Site Management and Monitoring), Asia, Middle East & Africa (AMEA) Senior Regional Director Melissa Grady said.
The unit will support development of AstraZeneca's medicines, hosting clinical trial experts focused on the company's core therapeutic areas - oncology, cardiovascular, renal and metabolism, as well as respiratory, the statement said.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)